Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: association with the severity of liver disease.

[1]  G. Barbarini,et al.  Epicardial fat thickness and nonalcoholic fatty liver disease in obese subjects , 2014, Obesity.

[2]  O. Faergeman,et al.  Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levels. , 2013, International journal of cardiology.

[3]  Kirsi Lauerma,et al.  Cardiac steatosis associates with visceral obesity in nondiabetic obese men. , 2013, The Journal of clinical endocrinology and metabolism.

[4]  G. MacGowan,et al.  Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease. , 2012, Journal of hepatology.

[5]  Jin Hwa Kang,et al.  Nonalcoholic fatty liver disease is associated with coronary artery calcification , 2012, Hepatology.

[6]  G. Kocabay,et al.  Relation of epicardial adipose tissue and carotid intima-media thickness in patients with nonalcoholic fatty liver disease , 2012, European journal of gastroenterology & hepatology.

[7]  Enrico Barbieri,et al.  Nonalcoholic Fatty Liver Disease Is Associated With Left Ventricular Diastolic Dysfunction in Patients With Type 2 Diabetes , 2012, Diabetes Care.

[8]  D. Dey,et al.  Weight change modulates epicardial fat burden: a 4-year serial study with non-contrast computed tomography. , 2012, Atherosclerosis.

[9]  G. Iacobellis,et al.  Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features , 2011, Trends in Endocrinology & Metabolism.

[10]  D. Harnois,et al.  Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease , 2011 .

[11]  D. Mikhailidis,et al.  Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis , 2010, The Lancet.

[12]  Giuseppe Lippi,et al.  Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[13]  H. Oflaz,et al.  Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: association with liver fibrosis. , 2010, Atherosclerosis.

[14]  M. Ermani,et al.  Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension. , 2009, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[15]  S. Grundy,et al.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.

[16]  A. Craxì,et al.  Non-alcoholic fatty liver disease pathogenesis: the present and the future. , 2009, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[17]  Arturo Evangelista,et al.  Recommendations for the evaluation of left ventricular diastolic function by echocardiography. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[18]  Mathias Prokop,et al.  Relation of epicardial and pericoronary fat to coronary atherosclerosis and coronary artery calcium in patients undergoing coronary angiography. , 2008, The American journal of cardiology.

[19]  J. Kench,et al.  Visceral fat: A key mediator of steatohepatitis in metabolic liver disease , 2008, Hepatology.

[20]  Arya M. Sharma,et al.  Relation of Epicardial Fat and Alanine Aminotransferase in Subjects With Increased Visceral Fat , 2008, Obesity.

[21]  P. Scifo,et al.  Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver , 2007, Hepatology.

[22]  L. N. Valenti,et al.  Carotid artery intima-media thickness in nonalcoholic fatty liver disease. , 2008, The American journal of medicine.

[23]  A. Sanyal,et al.  The impact of fat distribution on the severity of nonalcoholic fatty liver disease and metabolic syndrome , 2007, Hepatology.

[24]  G. Targher,et al.  Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic Patients , 2007, Diabetes Care.

[25]  Arya M. Sharma,et al.  Relation of subepicardial adipose tissue to carotid intima-media thickness in patients with human immunodeficiency virus. , 2007, The American journal of cardiology.

[26]  S. Goland,et al.  Cardiac Abnormalities as a New Manifestation of Nonalcoholic Fatty Liver Disease: Echocardiographic and Tissue Doppler Imaging Assessment , 2006, Journal of clinical gastroenterology.

[27]  William Stewart,et al.  Recommendations for chamber quantification. , 2006, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[28]  N. Clark,et al.  Standards of Medical Care in Diabetes: Response to Power , 2006 .

[29]  L. N. Valenti,et al.  Risk of early atherosclerosis evaluated by carotid artery intima-media thickness in patients with non-alcoholic fatty liver disease : a case control study , 2006 .

[30]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[31]  Emilio Ros,et al.  Nonalcoholic Fatty Liver Disease Is Associated With Carotid Atherosclerosis: A Case–Control Study , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[32]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[33]  F. Leonetti,et al.  Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. , 2003, The Journal of clinical endocrinology and metabolism.

[34]  G. Leandro,et al.  Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. , 2003, Journal of hepatology.

[35]  F. Leonetti,et al.  Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. , 2003, Obesity research.

[36]  S. Corrao,et al.  Heredity and obesity-associated hypertension: impact of hormonal characteristics and left ventricular mass , 1995, Journal of hypertension.

[37]  S. Daniels,et al.  Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. , 1992, Journal of the American College of Cardiology.